BackFidelity Advisor Health Care Fund Class M Overview

Fidelity Advisor Health Care Fund Class M EBIT

Latest ebit for FACTX: $66M, below the sector sector average of $2.6T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$26.44M
↓ 1.31% YoY

As of Jan 31, 2024

Annual EBIT (TTM)

$66.10M
↑ 5.69% YoY

Trailing 12 months ending Jan 31, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Fidelity Advisor Health Care Fund Class M (FACTX) FAQ

The latest EBIT for FACTX is $66M as of January 2024. That compares with $63M in the prior-year period — up 5.7% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Fidelity Advisor Health Care Fund Class M's historical trend and sector peers before judging valuation or financial health.

Over the past year, FACTX's EBIT moved from $63M to $66M — a 5.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fidelity Advisor Health Care Fund Class M's operating scale or balance-sheet position.

Against its sector companies, FACTX currently prints $66M for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Fidelity Advisor Health Care Fund Class M's growth, margins, and balance sheet.

A EBIT figure of $66M for FACTX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting FACTX's EBIT ($66M), review year-over-year change from $63M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.